MU nears $1,000 as Apple's China memory stance could boost U.S. chip makers and memory ETFs.

Biotech ETFs are riding a powerful rally fueled by innovation, obesity drugs and M&A, with three funds offering diversified exposure to growth.

U.K. ETFs are gaining attention as resilient growth, strong FTSE performance and supportive sector trends put the market in focus.

U.S. consumer spending may lose steam as tax-refund support fades, real cash flow stagnates and lower-income shoppers turn cautious. Here are ETFs to gain or lose.

SK Hynix's massive buyback and strong AI-driven memory demand could provide a fresh catalyst for the stock and ETFs with exposure to the chipmaker.

Bitcoin's rebound above $69,000, strong ETF inflows and a more supportive macro backdrop could offer fresh upside for Bitcoin ETFs.

CANC hits a 52-week high as strong oncology developments and positive momentum fuel the biotech ETF's rally.

Cybersecurity ETFs gain momentum as cyber leaders like FTNT post strong Q2 results, fueled by rising AI-driven threats and demand for security.

Rising Treasury yields and persistent inflation are creating a challenging bond-market backdrop. Here are ETFs that could help investors navigate higher rates.

Is it time to look beyond the U.S. markets? Improving flows and dollar weakness are putting emerging market ETFs in focus.